Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)

NCT04219098
completednot_applicable

Pocket Sized Ultrasound (PsUS) and Pediatric Elbow Fractures

NCT05870345
completednot_applicable

Feasibility and Acceptability of Butterfly iQ

NCT05054504
completednot_applicable

COVID-19 and Lung Ultrasound Utility

NCT04591158

Clinical Trials (4)

Showing 4 of 4 trials
NCT04219098Not Applicable

Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)

Completed
NCT05870345Not Applicable

Pocket Sized Ultrasound (PsUS) and Pediatric Elbow Fractures

Completed
NCT05054504Not Applicable

Feasibility and Acceptability of Butterfly iQ

Completed
NCT04591158Not Applicable

COVID-19 and Lung Ultrasound Utility

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4